Business Context and Reporting Period
Shuttle Pharmaceuticals Holdings, Inc. (SHPH) filed a Current Report on Form 8-K dated August 31, 2026. The filing reports the entry into a material definitive agreement regarding a previously announced merger with United Dogecoin Inc., a wholly-owned subsidiary of the Company.
Key Financial Metrics
This filing is a current report regarding a contractual amendment and does not contain financial statements. Consequently, the filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
On August 31, 2026, the Company entered into a First Amendment to the Merger Agreement dated April 30, 2026. The material change is as follows:
- Milestone Event Threshold Reduction: The definition of "Milestone Event" was amended to reduce the required number of Mining Rigs from 2,000 to 500.
- Unchanged Terms: The maximum number of pre-funded warrants (or underlying common stock) issuable upon satisfying the Milestone Event remains unchanged.
- Parallel Amendments: The Company is seeking approval from investors and other parties to effect similar amendments to the Securities Purchase Agreement (related to the PIPE Financing closed May 6, 2026) and the Second Amendment to the Asset Purchase Agreement.
Guidance, Outlook, and Risks
The filing includes forward-looking statements regarding the Company's efforts to secure requisite approvals for the Parallel Amendments. Management notes that actual outcomes may differ materially from predictions due to uncertainties in obtaining these approvals. The Company explicitly states it undertakes no obligation to revise or update these forward-looking statements.
Investor Verification Checklist
- Verify the status of approvals required from Purchasers under the Securities Purchase Agreement and parties to the Second Amendment to Asset Purchase Agreement.
- Confirm the impact of the reduced Mining Rig threshold (500 vs. 2,000) on the Company's operational roadmap and capital requirements.
- Review the attached Exhibit 10.1 (First Amendment to Merger Agreement) for any additional covenants or conditions not summarized in the text.
- Monitor subsequent filings for confirmation that the Parallel Amendments have been successfully executed.